Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Darbepoetin alfa Biosimilar (Ivy Pharma, Inc.), 达依泊汀α 生物类似药(Ivy Pharma, Inc.), IVY 8305 + [1] |
Target |
Action agonists |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia | Preclinical | United States | 01 Nov 2024 |






